Experimental infection and protection against ... - TI Pharma

General Discussion 239
85. Beier JC, Davis JR, Vaughan JA, Noden BH, Beier MS. Quantitation of
Plasmodium falciparum sporozoites transmitted in vitro by experimentally
infected Anopheles gambiae and Anopheles stephensi. Am J Trop Med Hyg
1991; 44:564-570.
86. Frischknecht F, Baldacci P, Martin B et al. Imaging movement of malaria
parasites during transmission by Anopheles mosquitoes. Cell Microbiol 2004;
6:687-694.
87. James SP. Report on the first results of laboratory work on malaria in England.
Publications of the League of Nations, Health Organization 1926;1-30.
88. Glynn JR, Bradley DJ. Inoculum size, incubation period and severity of malaria.
Analysis of data from malaria therapy records. Parasitology 1995; 110 [ Pt 1):7-
19.
89. Collins WE, Jeffery GM. A retrospective examination of secondary sporozoite-
and trophozoite-induced infections with Plasmodium falciparum: development
of parasitologic and clinical immunity following secondary infection. Am J Trop
Med Hyg 1999; 61:20-35.
90. Shute PG, Lupascu G, Branzei P et al. A strain of Plasmodium vivax characterized
by prolonged incubation: the effect of numbers of sporozoites on the length of
the prepatent period. Trans R Soc Trop Med Hyg 1976; 70:474-481.
91. Ungureanu E, Killick-Kendrick R, Garnham PC, Branzei P, Romanescu C, Shute
PG. Prepatent periods of a tropical strain of Plasmodium vivax after inoculations
of tenfold dilutions of sporozoites. Trans R Soc Trop Med Hyg 1976; 70:482-483.
92. Jeffery GM, Rendtorff RC. Preservation of viable human malaria sporozoites by
low-temperature freezing. Exp Parasitol 1955; 4:445-454.
93. Mayne B. The injection of mosquito sporozoites in malaria therapy. Pub Health
Rep 1933;909-913.
94. Mayne B. The technique of induced malaria as used in the South Carolina State
Hospital. Venereal Disease Information 1941; 22:271-276.
95. Ballou WR, Hoffman SL, Sherwood JA et al. Safety and efficacy of a recombinant
DNA Plasmodium falciparum sporozoite vaccine. Lancet 1987; 1:1277-1281.
96. Herrington DA, Clyde DF, Losonsky G et al. Safety and immunogenicity in man of
a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites.
Nature 1987; 328:257-259.
97. Ifediba T, Vanderberg JP. Complete in vitro maturation of Plasmodium
falciparum gametocytes. Nature 1981; 294:364-366.
98. Campbell CC, Collins WE, Nguyen-Dinh P, Barber A, Broderson JR. Plasmodium
falciparum gametocytes from culture in vitro develop to sporozoites that are
infectious to primates. Science 1982; 217:1048-1050.
99. Hoffman SL, Billingsley PF, James E et al. Development of a metabolically active,
non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria.
Hum Vaccin 2010; 6:97-106.
100. Epstein JE, Tewari K, Lyke KE et al. Live attenuated malaria vaccine designed to
protect through hepatic CD8 T cell immunity. Science 2011; 334:475-480.